GSTM1 and anemia (phenotype): The randomised study presented here compared the efficacy and safety of iv FCM given at weight‐ and Hb‐adjusted doses according to the summary of product characteristics (SmPC) and oral FeSulf in patients with anaemia secondary to non‐variceal acute GIB, aiming to improve the evidence base in lieu of established treatment protocols.